Telomerase is a ribonucleoprotein enzyme that is required for the maintenance of telomere repeats. Although overexpression of telomerase in normal human somatic cells is sufficient to overcome replicative senescence, the ability of telomerase to promote tumorigenesis requires additional activities that are independent of its role in telomere extension. Here, we identify proliferationassociated nucleolar antigen 120 (NOL1, also known as NOP2) as a telomerase RNA component (TERC)-binding protein that is found in association with catalytically active telomerase. Although NOL1 is highly expressed in the majority of human tumor cells, the molecular mechanism by which NOL1 contributes to tumorigenesis remained unclear. We show that NOL1 binds to the T-cell factor (TCF)-binding element of the cyclin D1 promoter and activates its transcription. Interestingly, telomerase is also recruited to the cyclin D1 promoter in a TERC-dependent manner through the interaction with NOL1, further enhancing transcription of the cyclin D1 gene. Depletion of NOL1 suppresses cyclin D1 promoter activity, thereby leading to induction of growth arrest and altered cell cycle distributions. Collectively, our findings suggest that NOL1 represents a new route by which telomerase activates transcription of cyclin D1 gene, thus maintaining cell proliferation capacity.
INTRODUCTION
Telomeres, the specialized nucleoprotein complexes located at the ends of eukaryotic chromosomes, are essential for maintenance of chromosome stability and genome integrity (Blackburn, 2001; Smogorzewska and de Lange, 2004) . Telomeric DNA is tightly associated with the six-subunit protein complex shelterin, which prevents chromosomal ends from being recognized as DNA damage (Palm and de Lange, 2008; Sfeir and de Lange, 2012) . In the absence of a telomere maintenance pathway, most human somatic cells show a progressive loss of telomeric DNA with each round of cell division due to the end replication problem (Lingner et al., 1995; Blasco et al., 1997) . The maintenance of telomere repeats in most eukaryotic organisms requires telomerase, which adds telomere repeats onto the 3′ ends of linear chromosomes by reverse transcription (Autexier and Lue, 2006; Bianchi and Shore, 2008) . Human telomerase consists of telomerase reverse transcriptase (hTERT), telomerase RNA component (TERC) and several additional proteins including dyskerin, TCAB1 (also known as WRAP53), pontin and reptin (Egan and Collins, 2012; Venteicher et al., 2008 ). Telomerase expression is very low in most human somatic cells but upregulated in many human cancer cells and stem cells, suggesting that activation of telomerase supports the continued cell proliferation (Kim et al., 1994) .
Although overexpression of telomerase is sufficient to overcome replicative senescence (Bodnar et al., 1998) , recent studies have suggested that besides its reverse transcriptase activity, telomerase has the noncanonical functions that contribute to cancer development and progression (Stewart et al., 2002; Li and Tergaonkar, 2014) . Ectopic expression of telomerase in human mammary epithelial cells results in enhanced expression of growth-promoting genes (Smith et al., 2003) . Transgenic induction of TERT in mouse skin epithelium has been shown to cause proliferation of quiescent stem cells (Sarin et al., 2005) . This function for TERT is independent of reverse transcriptase activity (Choi et al., 2008) . In addition, TERT has been found to directly interact with BRG1 (also known as SMARCA4) and activate transcription of Wnt/β-catenin-dependent genes such as cyclin D1 and Myc (Park et al., 2009 ). However, the proposed noncanonical role of TERT in the Wnt/β-catenin signaling cascade has been controversial. Several studies have reported a lack of physical association of TERT with BRG1 or β-catenin (Listerman et al., 2014) , as well as no apparent effect of TERT deficiency on phenotypes associated with Wnt signaling in TERT-knockout mice (Strong et al., 2011) . Although TERT appears to regulate the expression of growth-promoting genes, this event might not be solely promoted by Wnt signaling. Indeed, TERT has been reported to bind to the NF-κB p65 subunit (also known as RelA) and activate NF-κB-dependent gene expression (Ghosh et al., 2012) .
Given that the large size of human telomerase suggests the existence of additional components, we performed a large-scale affinity purification to identify proteins that interact with telomerase. Here, we identify proliferation-associated nucleolar antigen p120 (NOL1, also known as NOP2) as a TERC-binding protein. NOL1 was originally identified as a RNA-binding and nucleolar-specific protein that is highly expressed in the majority of human malignant tumor cells but not in normal resting cells (Ochs et al., 1988; Jhiang et al., 1990; Fonagy et al., 1992 Fonagy et al., , 1993 . Although NOL1 has been implicated as a tumor cell marker (Gorczyca et al., 1992) , the molecular mechanism by which NOL1 contributes to tumorigenesis is poorly understood. We show that NOL1 binds to the T-cell factor (TCF)-binding element (TBE) of the cyclin D1 promoter and activates its transcription. Telomerase is also recruited to the cyclin D1 promoter through the interaction with NOL1, further enhancing transcription of cyclin D1 gene. These results suggest a new role for telomerase as a modulator of NOL1-dependent transcriptional activation in human cancer cells.
RESULTS

Identification of NOL1 as an hTERT-interacting factor
To identify proteins that interact with hTERT, we expressed Flagtagged hTERT in HEK293 cells and isolated hTERT complex using large-scale affinity purification. Proteins co-purified with FlaghTERT were identified by nano-liquid chromatography-tandem mass spectrometry (nano LC-MS/MS). Among the known telomerase components, TCAB1 and nucleolin were enriched in the hTERT complex (Fig. 1A) . In addition, analysis of a band migrating with an approximate relative molecular mass of 120 kDa was identified as NOL1, a highly conserved, nucleolar-specific RNA-binding protein (Ochs et al., 1988; Jhiang et al., 1990) . Given that NOL1 has been detected in proliferating tissues but not in normal resting cells, it has been implicated as a tumor cell marker. Thus, we wanted to investigate the role of NOL1 in telomerase function.
To determine whether hTERT and NOL1 associate in vivo, HEK293 cells were co-transfected with Flag-hTERT and NOL1-V5 expression vectors and subjected to immunoprecipitation. NOL1-V5 was specifically bound to Flag-hTERT that was immunoprecipitated from HEK293 cells (Fig. 1B) . Reciprocal immunoprecipitation showed that Flag-hTERT was detected in anti-V5 immunoprecipitates, indicating that hTERT associates with NOL1 in mammalian cells. Interestingly, the interaction between Flag-hTERT and NOL1-V5 was disrupted by RNase A treatment of the extract, which degrades TERC. Endogenous NOL1 was immunoprecipitated by endogenous hTERT, and this association was also disrupted by RNase A treatment (Fig. 1C) , suggesting that NOL1 can associate with hTERT through TERC binding in intact cells. These findings were further verified by immunoprecipitation experiments with U2OS cells, which lack endogenous hTERT and TERC (Jegou et al., 2009) . In this cellular background, Flag-hTERT did not interact with NOL1-V5 owing to a lack of TERC (Fig. 1D) . Taken together, these results suggest that NOL1 is a new TERC-binding protein. were subjected to immunoprecipitation (IP) with anti-Flag and anti-V5 antibodies, followed by immunoblotting with anti-V5 and anti-Flag antibodies. The indicated extracts were treated with 0.1 mg/ml RNase A during immunoprecipitation to degrade TERC. (C) HEK293 cells were subjected to immunoprecipitation with anti-hTERT antibody, followed by immunoblotting with anti-NOL1 antibody. IgG was used as a negative control. (D) Telomerase-negative U2OS cells expressing Flag-hTERT and NOL1-V5 were subjected to immunoprecipitation with anti-Flag antibody, followed by immunoblotting with anti-V5 antibody.
amino acid residues 1-589. Because this region contains the TERC-binding domain (TRBD), we examined whether the TRBD is required for NOL1 binding to hTERT. The results showed that removing the TRBD on hTERT abolished NOL1 binding (Fig. 2C,D) , further supporting the idea that the association of NOL1 with hTERT is dependent on TERC. To map the region in NOL1 that is required for TERC binding, we generated deletion constructs lacking a coiled-coil domain or a putative rRNA methyltransferase (MTase) domain ( Fig. 2E) (Koonin, 1994; Gustafson et al., 1998) . Flag-hTERT immunoprecipitated NOL1 fragments encompassing amino acid residues 380-583 (Fig. 2F) , indicating that the rRNA methyltransferase domain is essential for TERC binding.
The finding that NOL1 associates with hTERT through TERC was further verified by immunoprecipitation experiments. HEK293 cells were transfected with either NOL1-V5 or NOL1-E-V5 (the minimal TERC-binding domain) and subjected to immunoprecipitation, followed by semi-quantitative RT-PCR to detect TERC. The results showed that TERC was specifically immunoprecipitated by NOL1-V5 and NOL1-E-V5 (Fig. 3A) . Dyskerin, which has been shown to interact with TERC, was used as a positive-binding control (Lee et al., 2014) . To further demonstrate that NOL1 directly interacts with TERC, we performed a GST pulldown assay with in vitro transcribed TERC. GST-NOL1-E, but not the control GST protein, bound efficiently to in vitro transcribed TERC, as did GST-dyskerin (Fig. 3B ).
NOL1 associates with catalytically active telomerase but does not affect telomerase enzymatic activity
Given that NOL1 associates with hTERT through TERC binding, we determined whether NOL1 is a telomerase holoenzyme subunit. HEK293 cells were co-transfected with NOL1-V5 and FlaghTERT, Flag-TCAB1 or Flag-dyskerin, and subjected to immunoprecipitation. NOL1-V5 was immunoprecipitated by Flag-TCAB1 and Flag-dyskerin, as observed for Flag-hTERT (Fig. 4A) . We next examined whether NOL1 associates with catalytically active telomerase. HEK293 cells expressing Flag-NOL1 or other Flag-tagged telomerase components were subjected to immunoprecipitation with anti-Flag antibody and analyzed for telomerase activity by a telomeric repeat amplification protocol (TRAP) assay. Immunoprecipitates of Flag-NOL1 contained telomerase activity (Fig. 4B) , as did those of Flag-hTERT, Flag- TCAB1 and Flag-dyskerin, indicating that NOL1 is a component of catalytically active telomerase.
To examine an involvement of NOL1 in telomerase function, the expression of endogenous NOL1 was stably depleted in HeLa S3 cells using short hairpin RNA (shRNA) produced from a retroviral vector. NOL1-knockdown cells maintained the reduced levels of NOL1 throughout the duration of the experiments (see below). Depletion of NOL1 did not affect the levels of telomerase components ( Fig. 4C ) and shelterin proteins (Fig. 4D ). We also found that depletion (Fig. 4E ) or overexpression of NOL1 (Fig. S1 ) did not affect telomerase activity. Taken together, these results indicate that although NOL1 associates with catalytically active telomerase, it has no direct regulatory effect on telomerase enzymatic activity.
NOL1 did not affect the subnuclear localization of telomerase
Telomerase undergoes a highly elaborate, stepwise process of assembly and trafficking within the nucleus (Lee et al., 2014) . If NOL1 is required for assembly and trafficking of active telomerase, we would expect NOL1 depletion to impair the subnuclear localization of hTERT. To examine this possibility, we depleted NOL1 in HeLa S3 cells and performed indirect immunofluorescence staining to determine the subnuclear localization of endogenous hTERT. Given that telomerase synthesizes telomeres specifically during S phase (Lee et al., 2010; Tomlinson et al., 2006) , HeLa S3 cells were synchronized at S phase using a double thymidine block (Lee et al., 2010) . In the shRNA control cells, the majority of hTERT was found to localize Lysates from HEK293 cells expressing Flag-NOL1, Flag-hTERT, Flag-TCAB1 or Flagdyskerin were immunoprecipitated with anti-Flag antibody and analyzed for telomerase activity by the TRAP assay. (C) HeLa S3 cells expressing control shRNA (shControl) or NOL1 shRNAs (shNOL1-1 and shNOL1-2) were subjected to immunoblotting, to measure the protein levels of telomerase components, and semi-quantitative RT-PCR, to detect the mRNA levels of telomerase components and TERC. (D) HeLa S3 cells expressing shControl or shNOL1 were subjected to immunoblotting to measure the levels of shelterin proteins. (E) HeLa S3 cells expressing shControl or shNOL1 were analyzed for telomerase activity by the TRAP assay. To test RNA-dependent extension, RNase A (0.25 mg/ml) was added to the extracts before the primer extension reaction when indicated. ITAS, internal telomerase assay standard.
to nucleoli (Fig. S2A,B) . The nucleolar localization of hTERT was not affected by NOL1 depletion. Telomerase has been shown to accumulate in Cajal bodies prior to telomere elongation ). Thus, we determined whether NOL1 depletion affects colocalization of hTERT with Cajal bodies during S phase. Cajal body localization of hTERT was not affected by NOL1 depletion, as indicated by dual staining with a coilin-specific antibody (Fig. S2C,D ). These results demonstrate that NOL1 does not affect the intranuclear trafficking of hTERT.
Dysfunctional telomeres are recognized by the canonical DNA damage signaling pathway, and the resulting telomere-dysfunctioninduced foci (TIFs) represent the foci of DNA damage response factors that coincide with telomeres (Takai et al., 2003; D'Adda di Fagagna et al., 2003) . To determine the role of NOL1 in telomeredamage pathway, the telomeric foci for 53BP1 and the phosphorylated H2AX marker (γH2AX) were examined in NOL1-knockdown cells. Depletion of NOL1 did not induce more telomere-damage foci in the nucleus compared to the control cells (Fig. S3 ), indicating that NOL1 is not involved in the control of a DNA damage response at telomeres.
NOL1 activates transcription of the cyclin D1 gene
NOL1 is a proliferation-related nucleolar protein that is highly expressed in the majority of human malignant tissues (Ochs et al., 1988; Jhiang et al., 1990) . It is expressed in the early G1 phase and peaks in S phase (Fonagy et al., 1992 (Fonagy et al., , 1993 Gorczyca et al., 1992) . Although the expression of NOL1 has been shown to be induced rapidly following growth stimulation and produce tumors in the nude mice (Perlaky et al., 1992) , the mechanism by which NOL1 exerts these effects is poorly understood. To investigate the role of NOL1 in the control of cell cycle and cell proliferation, we examined the effect of NOL1 depletion on the expression of cellcycle-dependent and proliferation-controlling genes such as cyclin D1 and Myc (Musgrove et al., 2011; Sears, 2004) . Interestingly, depletion of NOL1 caused a clear reduction in the expression of cyclin D1 as shown by immunoblot analysis, as well as in the levels of cyclin D1 mRNA as demonstrated by semi-quantitative RT-PCR experiments, suggesting that NOL1 regulates the expression of cyclin D1 gene at the transcription level (Fig. 5A) . By contrast, the expression of c-Myc was not affected by NOL1 depletion, suggesting that the effect of NOL1 is specific to the promoter. We also found that overexpression of NOL1 increased the expression of cyclin D1 but did not influence the expression of c-Myc (Fig. S1A) . It has been reported that telomerase modulates Wnt/β-catenin signaling by acting as a transcriptional cofactor at Wnt target genes (Park et al., 2009 ). Thus, we examined whether NOL1-mediated transcriptional activation of cyclin D1 gene is dependent on telomerase. The effect of NOL1 depletion on the cyclin D1 expression was examined in telomerase-negative U2OS cells. Essentially, similar results to those seen in telomerase-positive HeLa S3 cells were obtained in this cell line (Fig. 5B) , indicating that NOL1-dependent activation of cyclin D1 transcription occurs regardless of telomerase expression.
Telomerase stimulates transcription of cyclin D1 gene through the interaction with NOL1
The cyclin D1 promoter contains several distinct transcriptionfactor-binding sites targeted by different signaling pathways (Pestell et al., 1999) . To determine the NOL1-responsive element, a series of 5′ cyclin D1 promoter deletion constructs were transfected in the presence of NOL1 expression. As shown in Fig. 5C , cyclin D1 transcription was induced about four-fold by NOL1 overexpression compared to the vector control. The proximal 85-base region, which contains the TBE, was essential for activation of the cyclin D1 promoter, suggesting that the TCF-binding site is a NOL1-responsive element.
We next examined the effect of NOL1 overexpression on TCF transcriptional activity by transfecting cells with the TCF-sensitive luciferase reporter vector (TOP-Flash) or TCF-insensitive control vector (FOP-Flash) in HeLa CCL2 cells. The results showed that ectopic expression of NOL1 increased TOP-Flash activity but not FOP-Flash activity (Fig. 5D) . Interestingly, ectopic expression of hTERT alone also induced TOP-Flash activity, which was further increased by co-expression of NOL1. To verify these findings, telomerase-positive H1299 and MCF7 cells were transfected with the −964 promoter luciferase reporter vector together with NOL1-V5 or Flag-hTERT or both. Overexpression of either NOL1 or hTERT led to an increase in cyclin D1 promoter activity compared to the vector control (Fig. 5E,F) . When both proteins were coexpressed, we observed an additive effect on cyclin D1 promoter activity. These results suggest that both NOL1 and hTERT are required for efficient cyclin D1 transcription.
Although NOL1 stimulates transcription of the cyclin D1 gene independently of hTERT, it is unclear whether hTERT alone is sufficient to activate cyclin D1 promoter activity without NOL1 binding. To test this possibility, dependence of NOL1 was examined in telomerase-negative U2OS cells. As shown in Fig. 5G , cyclin D1 promoter activity was increased by NOL1 overexpression but not by hTERT overexpression. Moreover, the additive effect was not observed upon overexpression of both proteins. These results could be due to a lack of TERC in U2OS cells. Taken together, these data suggest that telomerase promotes transcription of cyclin D1 gene through the interaction with NOL1.
Both NOL1 and hTERT associate with the cyclin D1 promoter at the TBE To determine whether both NOL1 and hTERT are recruited to the TBE of cyclin D1 promoter, we carried out chromatin immunoprecipitation (ChIP). HeLa S3 cells expressing Flag-NOL1 (or empty vector) and hTERT shRNAs (or control shRNA) were cross-linked with formaldehyde, followed by immunoprecipitation with anti-Flag antibody. The immunoprecipitated chromatin was used as a template to amplify the TBE in the cyclin D1 promoter. The results showed that anti-Flag antibody immunoprecipitated the TBE-containing fragments when Flag-NOL1 was overexpressed (Fig. 6A ). This TBE signal was not altered by depletion of endogenous hTERT, indicating that NOL1 binds to the TBE independently of hTERT. No amplification was observed when the immunoprecipitated chromatin was used to amplify the 3′-untranslated region (3′-UTR) (Fig. 6A) . Because transcriptional activation by NOL1 is specific to the promoter, we examined whether NOL1 is recruited to the Myc promoter and found that the Flag-NOL1 ChIP signal was not detected at the TBE of the Myc promoter (Fig. 6B) . We next examined the effect of hTERT depletion on the cyclin D1 transcription. In HeLa CCL2 cells expressing empty vector, depletion of hTERT reduced cyclin D1 promoter activity (Fig. 6C) . However, in cells expressing Flag-NOL1, cyclin D1 promoter activity was not significantly affected by depletion of hTERT, further supporting the idea that NOL1 activates transcription of cyclin D1 regardless of hTERT expression.
To determine whether the occupancy of the cyclin D1 promoter by hTERT is dependent on NOL1, HeLa S3 cells expressing FlaghTERT (or empty vector) and NOL1 shRNAs (or control shRNA) were subjected to ChIP. Flag-hTERT associated with the TBEcontaining fragment of the cyclin D1 promoter in cells expressing control shRNA (Fig. 6D) . When endogenous NOL1 was depleted, the ability of Flag-hTERT to bind to the TBE fragment was abrogated. These results suggest that hTERT can be recruited to the cyclin D1 promoter through the interaction with NOL1. Intriguingly, the faint but consistent ChIP signal of Flag-hTERT was detected at the TBE fragment of the Myc promoter in a NOL1-independent manner (Fig. 6E) . We also examined the effect of NOL1 depletion on the cyclin D1 transcription. As expected, cyclin D1 promoter activity was reduced by NOL1 depletion in HeLa CCL2 cells (Fig. 6F) . Even in the presence of overexpression of hTERT, cyclin D1 promoter activity was also reduced by NOL1 depletion (Fig. 6F) , suggesting that hTERT activates cyclin D1 transcription in a NOL1-dependent manner.
To further validate the co-occupancy of NOL1 and hTERT in the cyclin D1 promoter, we performed a ChIP-re-ChIP assay (Qiu et al., 2013) . HeLa S3 cells expressing Flag-hTERT and NOL1-V5 were subjected to ChIP with anti-Flag antibody, followed by re-ChIP using anti-V5 antibody. Flag-hTERT alone bound to the cyclin D1 TBE (Fig. 7A) . Interestingly, this binding was increased by coexpression of NOL1-V5. These results are consistent with the previous findings that co-expression of both proteins led to an additive effect on cyclin D1 promoter activity (see Fig. 5E,F) . When a sequential ChIP (re-ChIP) assay was performed, we observed that Flag-hTERT associates with the cyclin D1 TBE only in the presence of NOL1-V5 overexpression (Fig. 7A) , further confirming that hTERT is recruited to the cyclin D1 TBE through the interaction with NOL1. In contrast, although Flag-hTERT associates with the Myc TBE in a NOL1-independent manner, the re-ChIP results demonstrated that NOL1-V5 does not associate with the Myc promoter (Fig. 7B) .
Transcriptional activation of cyclin D1 gene is regulated by many other factors including c-Myc, NF-κB and β-catenin during the cell cycle (Pestell et al., 1999) . β-catenin has been shown to occupy the TBE to activate transcription of cyclin D1 gene in the presence of Wnt signaling (Park et al., 2009) , whereas c-Myc and NF-κB associate with other binding sites on the cyclin D1 promoter. To examine whether NOL1 depletion has any effect on β-catenin recruitment to the cyclin D1 TBE, HeLa S3 cells expressing Flag-β-catenin (or empty vector) and NOL1 shRNA (or control shRNA) were subjected to ChIP. Flag-β-catenin became associated with the TBE at the basal level in a NOL1-independent manner (Fig. 7C) . This association was markedly increased upon stabilization of β-catenin by lithium chloride (LiCl) treatment but was not affected by NOL1 depletion (Fig. 7C) .
Depletion of NOL1 induces cell growth arrest
Because cyclin D1 plays an important role in the cell cycle progression through G1 phase (Yu et al., 2001) , we determined the effect of NOL1 depletion on cell growth. HeLa S3 cells were transduced with the retrovirus particles expressing NOL1 shRNAs or control shRNA, and stable cell lines were established from separate transductions to monitor the population doubling levels at regular intervals. HeLa S3 cells expressing the control shRNA grew normally and continued to divide throughout the duration of the experiments (Fig. 8A ). The growth rates of two independent NOL1-knockdown cells (shNOL1-1 and shNOL1-2) gradually slowed down and stopped dividing after ∼50 population doublings and ∼30 population doublings, respectively. To determine whether the growth arrest correlates with an altered cell cycle distribution, NOL1-knockdown cells were subjected to flow cytometric analysis by propidium iodide staining. During the first few population doublings, NOL1-knockdown cells did not exhibit a substantial change in the cell cycle distribution compared with the control cells (Fig. 8B) . By contrast, NOL1-knockdown cells exhibited a substantial increase in sub-G1 DNA content at later population doublings, a characteristic of apoptosis (Fig. 8C) . Thus, the growth arrest of NOL1-knockdown cells appeared to be due to an increased rate of cell death. In addition, NOL1-knockdown cells showed increased levels of Bax and cleaved caspase-3, and decreased levels of anti-apoptotic Bcl-2 protein (Fig. 8D) . Taken together, these data support the idea that a growth-arrest phenotype associated with NOL1 depletion results from suppression of cyclin D1 transcription. Fig. 7 . hTERT is recruited to the cyclin D1 TBE through the interaction with NOL1. (A,B) HeLa S3 cells expressing FlaghTERT and NOL1-V5 were subjected to ChIP with anti-Flag antibody, followed by reChIP using anti-V5 antibody. The recruitment of Flag-hTERT and NOL1-V5 to the cyclin D1 TBE (A) or c-Myc TBE (B) was quantified by performing a gel-based semi-quantitative RT-PCR assay. The 3′-untranslated region (3′-UTR) was used as a negative control. (C) HeLa S3 cells expressing Flag-β-catenin (or empty vector) and control shRNA (shControl) or NOL1 shRNAs (shNOL1-1 and shNOL1-2) were subjected to ChIP with anti-Flag antibody in the absence or presence of LiCl treatment. The recruitment of Flag-β-catenin to the cyclin D1 TBE was quantified by performing a gel-based semi-quantitative RT-PCR assay. The 3′-UTR was used as a negative control.
As a control, we also examined the effect of cyclin D1 depletion on the cell cycle status (Fig. S4A) . Depletion of cyclin D1 led to an increase in the proportion of cells in sub-G1 phase compared to the control cells (Fig. S4B,C) .
DISCUSSION
Given that normal human somatic cells express very low levels of telomerase, they have a limited proliferative lifespan and ultimately enter a non-dividing state of replicative senescence (Bodnar et al., 1998) . Although ectopic expression of telomerase is sufficient to extend lifespan, recent studies have suggested that the ability of telomerase to promote tumorigenesis requires additional activities that are independent of its role in telomere extension (Stewart et al., 2002; Li and Tergaonkar, 2014) . Here, we identify NOL1 as a new TERC-binding protein that is found in association with catalytically active telomerase. Given that NOL1 has no direct regulatory effect on the assembly and trafficking of telomerase or its enzymatic activity, it is likely that NOL1 is involved in a non-telomeric function of telomerase. We show that NOL1 activates transcription of cyclin D1 gene by binding to the TBE. Telomerase is also recruited to the cyclin D1 promoter through the interaction with NOL1, further enhancing transcription of cyclin D1 gene. These data suggest that NOL1 represents a new pathway by which telomerase activates transcription of the cyclin D1 gene.
Besides its primary role in telomere extension, telomerase has been demonstrated to have non-canonical functions in signaling pathways that influence human tumorigenesis (Choi et al., 2008; Park et al., 2009; Ghosh et al., 2012) . Telomerase has been shown to bind the NF-κB p65 subunit and localize to the promoters of a subset of NF-κB target genes (Ghosh et al., 2012) . Inhibition of telomerase reduces the expression of NF-κB-dependent genes, suggesting that telomerase acts as a transcriptional modulator of the NF-κB signaling cascade in cancer cells. Telomerase has also been found to act as a transcriptional modulator of Wnt/β-catenin signaling pathway and enhance the expression of Wnt target genes (Park et al., 2009) . Moreover, overexpression of alternatively spliced variants that lack telomerase activity stimulate cell proliferation by activating Wnt signaling (Hrdlicková et al., 2012) . Given that Wnt signaling target genes are also regulated by other signaling pathways (Guo and Wang, 2009) , the mechanism by which telomerase enhances the expression of growth-promoting genes cannot be solely dependent on Wnt signaling. Recently, it has been reported that telomerase regulates Myc-dependent oncogenesis by stabilizing Myc levels on chromatin (Koh et al., 2016) . Taken together, these findings suggest that telomerase contributes to activation of growth-promoting genes through multiple signaling pathways in cancer. In this work, we show that telomerase interacts with NOL1 and promotes transcription of the cyclin D1 gene in the absence of Wnt or NF-κB signaling. Whereas NOL1 alone is sufficient to bind the cyclin D1 promoter and promote its transcription, hTERT is recruited to the cyclin D1 promoter through its interaction with NOL1, suggesting that telomerase activates cyclin D1 transcription in a NOL1-dependent manner. Whereas TERC is not required for telomerase-dependent transcriptional activation of Wnt/β-catenin signaling, it is essential for transcriptional activation by NOL1 and telomerase. Moreover, domain mapping analysis has revealed that the TERC-binding domain in hTERT is required for NOL1 binding, further supporting the idea that the association between NOL1 and hTERT is dependent on TERC. Thus, a functional interplay between NOL1 and telomerase modulates the prolonged expression of the cyclin D1 gene that is crucial for the maintenance of cell proliferation. Interestingly, it has been recently reported that non-canonical NF-κB signaling can upregulate mutant hTERT promoter activity along with ETS transcription factors . Reactivated hTERT can induce the binding of NOL1 to the cyclin D1 promoter by setting a potential feed-forward loop in cell proliferation.
NOL1 is a proliferation-related nucleolar protein that is highly expressed in most malignant tumor cells but not in normal resting cells (Ochs et al., 1988; Jhiang et al., 1990) . Given that telomerase is initially assembled in the nucleolus (Lee et al., 2014) , the finding that NOL1 is a new component of catalytically active telomerase suggests that the nucleolus could be the site where NOL1 associates with the telomerase holoenzyme. Based on data presented in this work, we propose a model for the two fates of telomerase during its initial assembly, telomere extension and transcriptional activation (Fig. 8E) . The assembly of the active telomerase holoenzyme occurs in a highly elaborate, stepwise fashion (Lee et al., 2014) . After transcription, a TERC molecule assembles with a preformed dyskerin complex, and the subsequent assembly of a TERC-dyskerin ribonucleoprotein (RNP) with hTERT occurs specifically during the S phase in the nucleolus. For telomere extension, telomerase associates with TCAB1 and is transported to Cajal bodies ). Telomerase-containing Cajal bodies are loaded on telomeric chromatin to elongate telomere repeats. By contrast, when NOL1 is recruited to the telomerase RNP in the nucleolus, the NOL1-telomerase complex binds to the cyclin D1 promoter at the TBE. Given that both TCAB1 and NOL1 associate with telomerase through the interaction with TERC, these two proteins might compete for binding to telomerase in the nucleolus. The outcome of this competition likely determines which of the two fates of telomerase is favored. Although we cannot rule out the possibility that both proteins exist in the same telomerase RNP, it is yet unclear what fractions of the telomerase RNP contain NOL1 or TCAB1. Recently, it has been reported that there are several hundred copies of telomerase RNP in a human cancer cell (Xi and Cech, 2014; Akıncılar et al., 2015) . Furthermore, the two telomerase components, hTERT and TERC, appear to be in excess of telomerase RNPs, suggesting the existence of unassembled telomerase components. Thus, it will be interesting to investigate how many molecules of NOL1 exist in a cell and how many of these are associated with TERC.
NOL1 has been shown to be expressed early in the G1 phase and peaks during the S phase (Fonagy et al., 1992 (Fonagy et al., , 1993 Gorczyca et al., 1992) . Thus, NOL1-dependent transcriptional activation of cyclin D1 gene might occur in a cell-cycle-dependent manner. When telomerase is upregulated in cancer cells, telomerase could interact with NOL1 and occupy the TBE of the cyclin D1 promoter to further enhance gene expression. Thus, NOL1 plays an important role in cell cycle progression through G1 phase and is implicated as a tumor cell marker. By contrast, repressing cyclin D1 expression by NOL1 depletion prevents the tumor cells exiting from G1 phase, reversing tumor characteristics. Consistent with this idea, depletion of NOL1 induced a growth arrest in telomerase-positive HeLa S3 cells. This growth arrest was accompanied by several features consistent with the induction of apoptosis, including a substantial increase in sub-G1 DNA content, an increase in the levels of Bax and cleaved caspase-3, and a decrease in the levels of anti-apoptotic Bcl2. These findings suggest that NOL1 plays a key role in the control of cell cycle progression through transcriptional activation of cyclin D1 gene. Overall, our results provide an insight into the new function of NOL1 as an important regulator of cell cycle and cell proliferation, as well as the non-canonical mechanism by which telomerase promotes cell proliferation in cancer cells.
MATERIALS AND METHODS
Cell culture and plasmids
Human cervical carcinoma HeLa cells and human embryonic kidney HEK293 cells were grown in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum with 100 units/ml penicillin and 100 μg/ml streptomycin in 5% CO 2 at 37°C. Human osteosarcoma U2OS cells were grown in McCoy's modified medium with 10% fetal bovine serum, 100 units/ml penicillin and 100 μg/ml streptomycin in 5% CO 2 at 37°C. The expression vectors for NOL1-V5 and Flag-NOL1 were constructed by inserting the full-length NOL1 cDNA into pcDNA 3.1/V5-His (Invitrogen) and p3xFlag-CMV 7.1 plasmid (Sigma-Aldrich), respectively. The FlaghTERT expression vector was constructed by cloning the full-length hTERT cDNA into a pCMV-Tag2 vector (Stratagene). The human cyclin D1 promoter luciferase plasmids were constructed by inserting the various promoter fragments into pGL4.20[luc2/Puro] vector (Promega). The expression vectors were transiently transfected using Lipofectamine-PLUS reagent according to the manufacturer's protocol (Invitrogen).
Peptide identification using LC-MS/MS
Nano LC-MS/MS analysis was performed with a nano HPLC system (Agilent) as previously described (Her and Chung, 2013) .
Immunoprecipitation and immunoblotting
Immunoprecipitation and immunoblot analyses were performed as described previously (Lee et al., 2004) . Briefly, cells were lysed with lysis buffer (0.5% NP-40, 0.5% Triton X-100, 150 mM NaCl, 2 mM EDTA, pH 8.0, 50 mM Tris-HCl, pH 7.5 and 10% glycerol) supplemented with a proteinase inhibitor cocktail (Roche) for 15 min at 4°C, followed by GST pulldown assay with in vitro transcribed TERC TERC transcripts were prepared by in vitro transcription using a MAXIscript T7/T3 Kit and cleared by MEGAclear Kit according to the manufacturer's recommendation (Ambion). For GST pulldown assays, GST fusion proteins (2 μg) were incubated with in vitro transcribed TERC (200 ng) in reaction buffer (10 mM HEPES, 3 mM KCl, 150 mM NaCl, 1 mM MgCl 2 ) supplemented with a proteinase inhibitor cocktail (Roche) and RNasin (20 U/ml, Promega). Complexes between GST fusion proteins and TERC were isolated with glutathione-Sepharose-4B (GE Healthcare) and used for semi-quantitative RT-PCR to detect TERC.
Telomerase assay
The telomeric repeat amplification protocol (TRAP) was used as previously described (Kim et al., 2003) .
Chromatin immunoprecipitation assay
HeLa S3 cells transfected with either Flag-NOL1 or Flag-hTERT were cross-linked with 1% formaldehyde in phosphate-buffered saline (PBS) for 30 min at room temperature and neutralized with addition of 125 mM glycine. Cells were lysed in lysis buffer (50 mM Tris-HCl, pH 8.0, 1% SDS, 10 mM EDTA) supplemented with a proteinase inhibitor cocktail (Roche). Chromatin was sonicated to obtain chromatin fragments with an average size of 600 bp, as assessed by electrophoresis on a 1% agarose gel. Sonicated samples were used for ChIP immunoprecipitation with Flag M2 agarose beads (Sigma-Aldrich) overnight at 4°C and pulled down by centrifugation (16,000 g) for 60 s. Chromatin-Flag-M2-agarose complexes were sequentially washed once with low-salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl, pH 8.0), high-salt buffer (low-salt buffer containing 500 mM NaCl), LiCl buffer (0.25 M LiCl, 0.5% NP-40, 0.5% Na-deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.0), and twice with TE buffer. For the re-ChIP assay, immune complexes were eluted from the agarose beads using 20 mM dithiothreitol and used for a secondary immunoprecipitation. DNA and proteins were recovered after incubation in 1% SDS and 0.1 M NaHCO 3 at 65°C, for 2 h. Then, NaCl was added to a 10 mM final concentration and protein-DNA cross-links were reversed by incubating samples at 65°C overnight. Finally, samples were digested with proteinase K at 45°C for 1 h. The isolated DNAs were analyzed by semi-quantitative RT-PCR. The primers for amplification of the TBE and 3′-UTR regions of each gene promoter were as follows: cyclin D1 TBE (forward, 5′-CGCTCCCATTCTCTGCCGGG-3′ and reverse, 5′-CCGCGCTCCCTCGCGCTCTT-3′), cyclin D1 3′-UTR (forward, 5′-C-AAGAGAAGATTACCGCCCGAG-3′ and reverse, 5′-TCCCCAGCCTTT-TTGACACC-3′), c-Myc TBE (forward, 5′-CGTCTAGCACCTTTGATTT-CTCCC-3′ and reverse, 5′-CTCTGCCAGTCTGTACCCCACCGT-3′), and c-Myc 3′-UTR (forward, 5′-CTAATGTATCACAAAGTCCTTTA-3′ and reverse, 5′-GTGATCTGCTCTGTTAGCTTTTGA-3′).
Dual luciferase reporter assay
HeLa cells were transiently co-transfected with cyclin D1 promoter luciferase reporter constructs, together with empty vector or NOL1-V5. At 24 h after transfection, cells were lysed, and firefly and Renilla luciferase activities were measured using the dual-luciferase reporter assay system (Promega). The firefly luciferase activity for each sample was normalized based on transfection efficiency as measured by Renilla luciferase activity. The results are expressed with the standard deviation from the mean of three independent experiments.
Establishment of stable cell lines
The retrovirus vectors were constructed by cloning the shRNA-expressing oligonucleotides targeting NOL1 (5′-GATCCCCGCGTTGCTGCCCAT-TGAAATTTTCAAGAGAAATTTCAATGGGCAGCAACGCTTTTTA-3′ for shNOL1-1; 5′-GATCCCCGGACGATGCTGATACGGTATTTTCAA-GAGAAATACCGTATCAGCATCGTCCTTTTTA-3′ for shNOL1-2) into pSUPER.retro.puro vector (OligoEngine). The retrovirus vectors expressing NOL1 shRNAs were co-transfected with pGP (for gag-pol expression) and pE-ampho (for env expression) into HEK293T packaging cells according to the manufacturer's instructions (Takara). After 48 h, the culture supernatants were harvested and filtered through a 0.45 μm filter. To generate stable cell lines, HeLa S3 cells were transduced with the viral supernatants containing 4 μg/ml polybrene (Sigma-Aldrich). After selection with 1 μg/ml puromycin (Gibco) for 2 weeks, multiple independent single clones were isolated and checked for NOL1 expression.
Fluorescence-activated cell sorting analysis
HeLa S3 cells were washed with PBS and fixed for 30 min in ice-cold 70% ethanol. The fixed cells were resuspended in PBS containing RNase A (200 μg/ml) and propidium iodide (50 μg/ml), and incubated in the dark for 30 min at room temperature. Cell cycle progression was monitored by flow cytometry using a FACScan flow cytometer (BD Biosciences).
Immunofluorescence and telomere fluorescence in situ hybridization
Cells grown on glass coverslips were fixed, permeabilized and blocked as described previously (Abreu et al., 2011) . Cells were incubated with rabbit anti-TERT (500 ng/ml, cat. no. 600-401-252, Rockland), mouse anti-coilin (2 μg/ml, cat. no. ab11822, Abcam), and mouse anti-nucleolin (200 ng/ml, cat. no. sc-17826, Santa Cruz Biotechnology) for 16 h at 4°C. After thorough washing with PBS, cells were incubated with Alexa-Fluor-488-conjugated anti-rabbit immunoglobulin (green) (cat. no. A-11034, Thermo Fisher) and Alexa-Fluor-568-conjugated anti-mouse immunoglobulin (red) (cat. no. A-11004, Thermo Fisher) for 1 h in the dark. The coverslips were mounted on microscope slides using Vectashield mounting medium with DAPI (Vector Laboratories). Immunofluorescence images were captured using a confocal laser-scanning microscope LSM 510 (Carl Zeiss). Telomere FISH staining was performed with Cy3-(CCCTAA) 3 PNA probe (Panagene) as previously described (van Steensel et al., 1998) .
